EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   3.1.3.56 | Muscular Diseases |
33792664 |
INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH. |
unassigned |
0 |
| 3.1.3.56 | Neoplasm Metastasis |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
causal interaction |
4 |
| 3.1.3.56 | Neoplasm Metastasis |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
unassigned |
0 |
| 3.1.3.56 | Neoplasms |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
causal interaction |
4 |
| 3.1.3.56 | Neoplasms |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
unassigned |
0 |
| 3.1.3.56 | Muscular Dystrophies |
33879025 |
Bidirectional interconversion between PtdIns4P and PtdIns(4,5)P2 is required for autophagic lysosome reformation and protection from skeletal muscle disease. |
causal interaction |
4 |
| 3.1.3.56 | Muscular Dystrophies |
33879025 |
Bidirectional interconversion between PtdIns4P and PtdIns(4,5)P2 is required for autophagic lysosome reformation and protection from skeletal muscle disease. |
unassigned |
0 |
